: ,
The STEP3 trial involved 611 patients with obesity or overweight, semaglutide 2.4 mg treatment demonstrated an average weight loss of 10.3%, with 86.6% of participants achieving over 5% weight reduction (vs
Long-Term Semaglutide Use: Safety and Effectiveness Extended semaglutide therapy extending beyond 2-3 years remains well-tolerated in most users, with no evidence of tachyphylaxis (loss of drug effect) or major cumulative safety concerns
[8] Uveitis is another inflammatory disorder of the eye tissues which is considered to lead to vision loss
Recent studies by the Gastroparesis Clinical Research Consortium (GCRC) in the USA, where full thickness gastric biopsies have been obtained in individuals with refractory gastroparesis, have yielded important insights relating to the pathophysiology of diabetic gastroparesis [11]
Understanding Vitamin B12 Deficiency and Injections If you're experiencing symptoms like depression, memory problems, fatigue, or tingling in your feet and hands, you might be suffering from a Vitamin B12 deficiency
